Actively Recruiting
Early Predictors of Necrotizing Enterocolitis in Neonates
Led by Nationwide Children's Hospital · Updated on 2025-06-29
450
Participants Needed
1
Research Sites
481 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this project is to identify neonates who are predisposed to Necrotizing Enterocolitis (NEC). the investigators will determine the effectiveness of non-invasive measures as well as biochemical markers to identify neonates early in the disease process. Thus, the investigators aim to identify infants with NEC prior to the onset of symptoms to institute or test treatments in the long term to prevent the progression of the disease in these infants.
CONDITIONS
Official Title
Early Predictors of Necrotizing Enterocolitis in Neonates
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Infants born at 30 weeks gestational age or earlier
- Infants with a birth weight of 1500 grams or less
You will not qualify if you...
- Gestational age at birth greater than 30 weeks
- Obvious dysmorphic syndromes
- Any abdominal wall defect including omphalocele or gastroschisis
- Any known intestinal atresia
- Complex cardiac abnormalities
- Any known lethal chromosomal abnormalities
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205
Actively Recruiting
Research Team
T
Theresa Pennington
CONTACT
J
Joanie Randle
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here